A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if galantamine augmentaion improves cognition in
euthymic bipolar patients. In addition, the effect of galantamine on clinical measures of
functioning and psychopathology will also be assessed.